EluSys Therapeutics Inc., of Pine Brook, N.J., appointed George Elston vice president of finance.
Entelos Inc., of Menlo Park, Calif., appointed Craig Shaffer managing director of professional services, and elected Roger Summit to its strategy and technology advisory board.
Genencor International Inc., of Palo Alto, Calif., appointed Cynthia Edwards vice president, technology and Molly Schmid senior director, functional genomics.
Idec Pharmaceuticals Inc., of San Diego, promoted Christine White to vice president, clinical oncology and hematology.
Idexx Laboratories Inc., of Westbrook, Maine, elected William End, chairman and CEO of Cornerstone Brands, to its board of directors.
La Jolla Pharmaceutical Co. Inc., of San Diego, said Chairman and CEO Steven Engle was elected to the Lupus Foundation of America board of directors.
MetaMorphix Inc., of Baltimore, appointed Anthony Barnes consultant, business development, poultry; Douglas Kolodny-Hirsh business development manager; and David Ozment, poultry field operations manager.
Mosaic Technologies Inc., of Boston, appointed Michael Furlong vice president of business development.
Nereus Pharmaceuticals Inc., of San Diego, named Kenneth Lloyd chief scientific officer and Donald Salz vice president of finance and administration.
Onyx Pharmaceuticals Inc., of Richmond, Calif., appointed Leonard Post senior vice president, research and development.
Orchid BioSciences Inc., of Princeton, N.J., appointed Leroy Hood to its scientific advisory board.
Photogen Technologies Inc., of Knoxville, Tenn., named Brooks Boveroux chief financial officer.